Objective: To observe the prevalence and characteristics of premonitory symptoms in Chinese migraineurs and explore their associations with migraine-related factors.
Method: Migraineurs who visited a tertiary headache clinic and one of nine neurology clinics between May 2014 and November 2019 were studied.
Result: Among the 4821 patients meeting the migraine criteria (International Classification of Headache Disorders, 3rd edition), 1038 (21.5%) patients experienced at least one premonitory symptom. The most common premonitory symptoms were neck stiffness, dizziness, yawning and drowsiness. The logistic regression analysis demonstrated that aura, photophobia, aggravation by routine physical activity, triggers, family history, depression, coffee consumption and physical exercise were associated with an increased probability of experiencing premonitory symptoms ( ≤ 0.001). The premonitory symptoms of migraine with and without aura differ in prevalence and most common symptoms. The cluster analysis revealed pairwise clustering of the following premonitory symptoms: Photophobia/phonophobia, concentration change/dysesthesia, loquacity/overactivity, yawning/drowsiness, fatigue/dizziness, and mood change/irritability. The correlation analysis of triggers and premonitory symptoms revealed that temperature change, environment change, sleep disorder, activity and stress were related to multiple premonitory symptoms, and that food, light, menstruation, alcohol and odor were related to special premonitory symptoms ( ≤ 0.001).
Conclusion: The prevalence of premonitory symptoms among migraineurs in China is 21.5%. Some factors influence the probability of experiencing premonitory symptoms. Paired premonitory symptoms in the clustering analysis may share similar origins. Certain triggers associated with multiple premonitory symptoms may induce brain dysfunction; however, other triggers that overlap with corresponding special premonitory symptoms may be premonitory symptoms or a form of premonitory symptom.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/0333102421997850 | DOI Listing |
J Headache Pain
December 2024
Eli Lilly and Company, Indianapolis, IN, USA.
Background: The total burden of migraine includes not only the episodes with headache pain but extends throughout the interictal periods. Interictal symptoms and associated psychological responses may profoundly impact well-being and drive treatment-seeking behavior.
Methods: A cross-sectional online survey was conducted with participants aged ≥ 18 years, 250 with episodic migraine (EM) and 250 with chronic migraine (CM), having ≥ 4 monthly migraine headache days.
Parkinsonism Relat Disord
November 2024
Movement Disorders Institute, Department of Neurology, Chiam Sheba Medical Center, Ramat-Gan, Israel; Center for Neurological Restoration, Neurological Institute, Cleveland Clinic Foundation, Cleveland, USA. Electronic address:
Cephalalgia
November 2024
Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
J Child Adolesc Psychopharmacol
November 2024
Neurology and Neurosurgery, Medical Director, Movement Disorders Neuromodulation & Brain Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Neurol Clin Pract
February 2025
Mayo Clinic (TJS), Phoenix, AZ; Albert Einstein College of Medicine (RBL), Bronx, NY; NIHR-King's Clinical Research Facility (PJG), King's College, London, United Kingdom; University of California (PJG), Los Angeles; Mayo Clinic (C-CC), Rochester, MN; Thomas Jefferson University (BCK), Philadelphia, PA; OPEN Health (CH), Parsippany, NJ; and AbbVie (CL, SYY, MF, JMT), North Chicago, IL.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!